Page 1 of Clinical Trials for OHSU Knight Cancer Institute [SPONSOR-COLLABORATORS], 82 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
MRI Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer
Last Updated: March 22, 2012
Condition(s): Brain Neoplasms
2
Recruiting
Imaging Vascular Properties of Pediatric Brain Tumors Using Ferumoxytol and Gadolinium in a Single Imaging Session
Last Updated: March 22, 2012
Condition(s): Brain Neoplasms
3
Not yet recruiting
BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain
Last Updated: March 7, 2012
Condition(s): Brain and Central Nervous System Tumors; Breast Cancer; Cognitive/Functional Effects; Drug/Agent Toxicity by Tissue/Organ; Psychosocial Effects of Cancer and Its Treatment
4
Terminated
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Last Updated: April 28, 2011
Condition(s): Cancer
5
Active, not recruiting
Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors
Last Updated: March 29, 2012
Condition(s): Breast Cancer; Cancer Survivor; Fatigue; Long-term Effects Secondary to Cancer Therapy in Adults; Psychosocial Effects of Cancer and Its Treatment
6
Recruiting
Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy
Last Updated: April 10, 2012
Condition(s): Breast Cancer
7
Terminated
Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery
Last Updated: June 3, 2010
Condition(s): Kidney Cancer
8
Completed
Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Last Updated: September 6, 2011
Condition(s): Kidney Cancer
9
Terminated
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer
Last Updated: March 28, 2012
Condition(s): Prostate Cancer
10
Completed
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
Last Updated: June 4, 2010
Condition(s): Breast Cancer; Menopausal Symptoms; Osteoporosis
11
Completed
Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Last Updated: February 15, 2011
Condition(s): Leukemia; Myelodysplastic Syndromes
12
Recruiting
Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Last Updated: March 29, 2012
Condition(s): Leukemia
13
Suspended
Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)
Last Updated: April 5, 2012
Condition(s): Recurrent Skin Cancer; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Squamous Cell Carcinoma of the Skin; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity
14
Recruiting
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, or Relapsed B-Cell Non-Hodgkin Lymphoma
Last Updated: March 26, 2012
Condition(s): Leukemia; Lymphoma
15
Withdrawn
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
Last Updated: December 12, 2011
Condition(s): Prostate Cancer
16
Recruiting
Melphalan With BBBD in Treating Patients With Brain Malignancies
Last Updated: March 22, 2012
Condition(s): Brain and Central Nervous System Tumors; Lymphoma; Metastatic Cancer
17
Active, not recruiting
Tissue Sample Collection From Patients With Fanconi Anemia
Last Updated: March 6, 2012
Condition(s): Fanconi Anemia; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
18
Active, not recruiting
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
Last Updated: September 22, 2011
Condition(s): Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell Tumor
19
Terminated
Imatinib Mesylate in Treating Patients With Myelofibrosis
Last Updated: December 1, 2011
Condition(s): Chronic Myeloproliferative Disorders
20
Terminated
Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy
Last Updated: September 9, 2010
Condition(s): Prostate Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=OHSU+Knight+Cancer+Institute

Page 1 of Clinical Trials for OHSU Knight Cancer Institute [SPONSOR-COLLABORATORS], 82 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About